KrishnansuSujataTewariMD

PubMed

• 35 citations
  Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
  Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen N Moore
  Journal of Clinical Oncology. 2022-03-20
• 29 citations
  Recombination of human papillomavirus‐16 and host DNA in exfoliated cervical cells: A pilot study of L1 gene methylation and chromosomal integration as biomarkers of c...
  Mina Kalantari, Dana M. Chase, Krishnansu S. Tewari, Hans-Ulrich Bernard
  Journal of Medical Virology. 2010-02-01
• 90 citations
  Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
  Robert L Coleman, Nick M Spirtos, Danielle Enserro, Thomas J Herzog, Paul Sabbatini
  The New England Journal of Medicine. 2019-11-14

Journal Articles

• Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG Oncology/Gynecologic Oncology Gro...  
  Hensley ML, Enserro D, Hatcher H, Ottevanger PB, Krarup-Hansen A, Blay JY, Fisher C, Moxley KM, Lele SB, Lea JS, Tewari KS, Thaker PH, Zivanovic O, O�Malley DM, Robiso..., J Clin Oncol, 1/5/2018
• Predictive modeling for determination of microscopic residual disease at primary cytoreduction: A NRG Oncology/Gynecologic Oncology Group 182 Study  
  Horowitz NS, Maxwell LG, Miller A, Hamilton CA, Rungruang B, Rodriguez N, Richard SD, Krivak TC, Fowler JM, Mutch DG, Van Le L, Lee RB, Argenta P, Bender D, Tewari KS,..., Gynecol Oncol, 1/1/2018
• Mutations in homologous recombination genes and outcomes in ovarian carcinoma patients in GOG 218: A NRG Oncology/Gynecologic Oncology Group Study  
  Norquist BM, Brady MF, Harrell MI, Walsh T, Lee MK, Gulsuner S, Bernards SS, Casedei S, Burger RA, Tewari KS, Backes F, Mannel RS, Glaser G, Bailey C, Rubin S, Soper J..., Clin Cancer Res, 1/1/2018
• Impact of tumor histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study  
  Seamon LG, Java JJ, Monk BJ, Penson RT, Brown J, Mannel RS, Oaknin A, Leitao MM. Eisenhauer EL, Long HJ, Liao SY, Tewari KS, Br J Cancer, 1/1/2018
• Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management  
  Grisham R, Ky B, Tewari KS, Chaplin DJ, Walker J, Gynecol Oncol Res Pract, 1/1/2018
• Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer  
  Worlford JE, Tewari KS, Expert Opin Drug Discov, 1/1/2018
• Cervical cancer � State of the science: From angiogenesis blockade to checkpoint inhibition  
  Minion LE, Tewari KS, Gynecol Oncol, 1/1/2018
• Correlation between surgeon�s assessment of residual disease and findings on postoperative pretreatment computed tomography scans in women with advanced stage ovarian ...  
  Eskander RN, J Kauderer J, Tewari KS, Bristow RE, Burger RA, Gynecol Oncol, 1/1/2018
• A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent end...  
  Aghajanian C, Filiaci V, Dizon DS, Carlson JW, Powell MA, Secord AA, Tewari KS, Bender DP, O�Malley DM, Stuckey A, Gao J, Dao F, Soslow RA, Lankes HA, Moore K, Devine LA, Gynecol Oncol, 1/1/2018
• Oncofertility in the setting of advanced cervical cancer � A case report  
  Gordon C, Carmichael JC, Tewari KS, Gynecol Oncol Rep, 1/1/2018
• Pharmacokinetic drug evaluation of niraparib for the treatment of ovarian cancer  
  Longoria TC, Tewari KS, Expert Opin Drug Metab Toxicol, 1/1/2018
• Bevacizumab in cervical cancer: 5 years after  
  Pfaendler KS, Liu MC, Tewari KS, Cancer J, 1/1/2018
• Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG o...  
  Tew WP, Sill MW, Walker JL, Secord AA, Bonebrake AJ, Schilder JM, Stuckey A, Rice L, Tewari KS, Aghajanian CA, Gynecol Oncol, 1/1/2018
• The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer  
  Minion LE, Tewari KS, Expert Rev Anticancer Ther, 1/1/2017
• Bevacziumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Grou...  
  Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Wwalker JL, Kim BG, Fujiwara K, Tewari KS, O�Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquis..., Lancet Oncol, 1/1/2017
• High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study  
  Reyes HD, Miecznikowski J, Gonzelez-Bosquet J, Devor EJ, Zhang Y, Thiel KW, Samuelson MI, McDonald M, Stephan JM, Hanjani P, Guntupalli S, Tewari KS, Backes F, Ramirez..., Gynecol Oncol, 1/1/2017
• A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic study  
  Chan JK, Deng W, Higgins R, Tewari KS, Bonebrake AJ, Hicks M, Gaillard S, Ramirez PT, Weldon C, Monk BJ, Aghajanian C, Gynecol Oncol, 1/1/2017
• Final overall survival of the phase III randomised trial of chemotherapy with and without bevacizumab for advanced cervical cancer: A NRG Oncology/Gynecologic Oncology...  
  Tewari KS, Sill MW, Penson RT, Long III HJ, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Sehman FB, Blessing JA, Brady MF, Burger RA,..., Lancet, 1/1/2017
• Highlights from the Gynecologic Oncology Track at the Annual Meeting of the American Society of Clincial Oncology  
  Wolford JE, Tewari KS, J Gynecol Oncol, 1/1/2017
• Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: A NR...  
  Moore KN, Tritchler D, Kaufman K, Lankes HA, Quinn MC, Van Le L, Berchuck A, Backes FJ, Tewari KS, Lee RB, Kesterson JP, Wenham RM, Armstrong DK, Krivak TC, Bookman MA..., Gynecol Oncol, 1/1/2017
• The ecstacy of gold: patient expirations for trastuzumab, bevacizumab, rituximab, and cetuximab  
  Serna-Gallegos TR, LaFargue CJ, Tewari KS, Recent Pat Biotechnol, 1/1/2017
• Changing paradigms in the systemic treatment of advanced cervical cancer  
  Pfaendler KS, Tewari KS, Am J Obstet Gynecol, 1/1/2016
• Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study  
  Tewari KS, Java JJ, Eskander RN, Monk BJ, Burger RA, Ann Oncol, 1/1/2016
• Clinical trials of anti-angiogenesis therapy in recurrent/persistent and metastatic cervical cancer  
  Alldredge JK, Tewari KS, Oncologist, 1/1/2016
• New targeted agents in gynecologic cancers: Synthetic lethality, homologous recombination deficiency, and PARP inhibitors  
  Liu FW, Tewari KS, Curr Treat Options Oncol, 1/1/2016
• Join now to see all

Books/Book Chapters

• University of California, Obstetrics & Gynecology, Women’s Health Review 
  Chapter: Invasive Cervical Cancer 
  Tewari KS, Monk BJEditors: DiSaia PJ.2011
• DiSaia & Creasman’s Clinical Gynecologic Oncology 
  Chapter: Cancer in Pregnancy 
  Tewari KSEditors: McMeekin SD, Mutch.Edition 8th,2011
• DiSaia & Creasman’s Clinical Gynecologic Oncology 
  Chapter: Invasive Cervical Cancer 
  Tewari KS, Monk BJEditors: McMeekin SD, Mutch.Edition 8th,2011
• Surgical Atlas of Gynecologic Oncology 
  Chapter: Clinical Trials 
  Tewari KS, Brewster WREditors: Bristow RE, Karlan BY.Edition 1st,2011
• University of California, Obstetrics & Gynecology, Women’s Health Review 
  Chapter: Neoplasia in Pregnancy 
  Tewari KSEditors: DiSaia PJ.2011
• Fellows� Handbook of Gynecologic Oncology 
  Chapter: A Brief History of Gynecologic Oncology in the United States 
  Tewari KS, Berman MLEditors: Ayhan A, Gultekin, M.European Society of Gynecologic OncologyEdition 1st,2009
• Fellows� Handbook of Gynecologic Oncology 
  Chapter: The Spectrum and Clinical Sequelae of Human Papillomavirus Infection 
  Martinez A, Tewari KS, Ferron G, Ramirez PTEditors: Ayhan A, Gultekin, M.European Society of Gynecologic OncologyEdition 1st,2009
• Clinical Gynecologic Oncology 
  Chapter: Cancer in Pregnancy 
  Tewari KSEditors: DiSaia PJ, Creasman WT.Mosby ElsevierEdition 7th,2007
• Clinical Gynecologic Oncology 
  Chapter: Invasive Cervical Cancer 
  Monk BJ, Tewari KSEditors: DiSaia PJ, Creasman WT.Mosby ElsevierEdition 7th,2007
• Textbook of Uncommon Cancers 
  Chapter: Tumors of the Cervix 
  Tewari KS, Monk BJEditors: Raghaven D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG, Mayer IA.WileyEdition 3rd,2006
• Surgery for Ovarian Cancer: Principles and Practice 
  Chapter: Cytoreductive Surgery in the Left Upper Abdomen 
  Tewari KS, Berman MLEditors: Bristow RE, Karlan BY.Taylor & Francis2005
• Maternal-Fetal Medicine: Principles and Practice 
  Chapter: Pelvic malignancies, Gestational Trophoblastic Neoplasia, and Nonpelvic malignancies 
  Berman ML, DiSaia PJ and Tewari KSEditors: Creasy RK, Resnik R.Saunders, Philadelphia, PAEdition 5th,2004
• The Best of After Office Hours 
  Chapter: The adventure of the three abnormal Paps 
  Tewari KSEditors: Pitkin RM, Rinehart RD.The American College of Obstetrics & Gynecology2003
• Cancer Diagnosis and Early Prevention in Women 
  Chapter: Vulvar neoplasia 
  Tewari KSEditors: Manetta A.Mosby Publication2003
• Surgery for Ovarian Cancer: Principles and Practice 
  Chapter: History of ovarian cancer surgery 
  Tewari KSEditors: Bristow RE, Karlan BY, Chi D.Edition 3rd,
• POC Gynecologic Cancer: Ovarian and Cervical Cancers 
  Chapter: Etiology and pathogenesis of cervical cancer 
  Tewari KSEditors: Tewari KS.
• POC Gynecologic Cancer: Ovarian and Cervical Cancers 
  Chapter: Screening and prevention of cervical cancer 
  Tewari KSEditors: Tewari KS.
• POC Gynecologic Cancer: Ovarian and Cervical Cancers 
  Chapter: Case study in cervical cancer 
  Tewari KSEditors: Tewari KS.
• Join now to see all

Abstracts/Posters

• Final protocol-specified overall survival and updated toxicity analysis in the phase III randomized trial of chemotherapy with and without bevacizumab for advanced cer...
  Tewari KS, Sill MW, Long HJ III, Penson RT, Huang HQ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael H, Monk BJ, Annual Meeting of the European Society of Medical Oncology, Madrid, Spain, 1/26/2014
• Impact of race, socioeconomic status, and the health system on the treatment of advanced-stage ovarian caner in California
  Long BJ, Chang J, Ziogas A, Tewari KS, Anton-Culver H, Bristow RE, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• Use of a dedicated pulley system to reestablish continuity of the vagina with the uterus at the time of fertility-preserving robotic assisted laparoscopic radical trac...
  Brueseke TJ, Tewari KS, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• Binary methylation of human papillomavirus (HPV) L1 and death-associated protein kinase (DAPK) as biomarkers of progression in cervical carcinogenesis
  Jordan SM, Kalantari M, Bernard HU, Calleja-Macias I, Kim S, Chase D, Tewari KS, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• Prospective validation of pooled clinical prognostic factors in patients with recurrent and advanced cervical cancer: A Gynecologic Oncology Group study
  Tewari KS, Sill MW, Monk BJ, Long HJ III, Penson RT, Huang HQ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael H, Moore DH, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• Human papillomavirus vaccination within a Southern California integrated healthcare system demonstrates disparities in adherence rates among males and females compared...
  Forde G, Tewari D, Bristow RE, Tewari KS, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• Assessment of palliative care training in gynecologic oncology: A Gynecologic Oncology Fellows Research Network study
  Eskander RN, Osann K, Dickson L, Holman L, Rauh-Hain A, SPoozak L, Wu E, Krill L, Nickles-Fader A, Tewari KS, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or prima...
  Coleman RL, Sill M, Aghajanian C, Gray HS, Tewari KS, Rubin S, Rutherford T, Chan J, Chen H, Swisher E, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• High-risk patients with recurrent/advanced cervical cancer may derive the most benefit from anti-angiogenesis therapy: A Gynecologic Oncology Group study
  Tewari KS, Sill MW, Moore DH, Long HJ III, Penson RT, Huang HQ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael H, Monk BJ, 45th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Tampa, FL, 1/22/2014
• Randomized phase 2 evaluation of bevacizuamb versus bevacizumab/fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: A Gynecologic Oncology Group study ...
  Monk BJ, Sill M, Walker J, DiSilvestro P, Sutton G, Tewari KS, Pajon E, Martin L, Schilder J, Coleman R, Balkssoon J, Aghajanian C, 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, Australia, 1/8/2014
• Prognostic impact of histology in recurrent and metastatic cervical carcinoma: A Gynecologic Oncology Group study
  Seamon LG, Java JJ, Monk BJ, Tewari KS, 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, Australia, 1/8/2014
• Fistulae in women treated with chemotherapy with and without bevacizumab for persistent, recurrent, or metastatic cervical cancer: A Gynecologic Oncology Group study
  Willmott L, Java JJ, Monk BJ, Shah J, Husain A, Tewari KS, 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, Australia, 1/8/2014
• A randomized phase II trial of bevacizuamb plus oral everolimus versus bevacizuamb alone for recurrent or persistent epithelial ovarian, fallopian tube, or primary per...
  Tew WP, Sill M, McMeekin DS, Secord AA, Bonebrake AJ, Schilder J, Stuckey A, Rice L, Tewari KS, Aghajanian C, 50th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/3/2014
• Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass
  Hodeib M, Bristow RE, Smith A, Chan DW, Zhang Z, Fung ET, Tewari KS, Munrose DG, Ueland FR, 42nd Annual Meeting of the Western Association of Gynecologic Oncologists, Seattle, WA, 1/27/2013
• A trial-based economic assessment of bevacizumab and chemotherapy versus chemotherapy alone for advance cervical cancer: Cost-effective analysis of Gynecologic Oncolog...
  Minion L, Tewari KS, Chan JK, Penson RT, Cohn DE, Monk BJ, Annual Meeting of the European Society of Gynaecological Cancer, Liverpool, England, 1/19/2013
• Pilot study of the PARO Therapeutic Robot demonstrates decreased pain, fatigue, and anxiety among patients with recurrent ovarian carcinoma
  Eskander RN, Osann K, Shibata T, Tewari KS, 44th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Los Angeles, CA, 1/9/2013
• Patients with microscopic residual disease experience decreased survival when time from surgery to initiation of chemotherapy exceeds 25 days: A Gynecologic Oncology G...
  Eskander RN, Java JJ, Tewari KS, Burger RA, Monk BJ, 44th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Los Angeles, CA, 1/9/2013
• Phase III randomized clinical trial of cisplatin plus paclitaxel vs. the non-platinum chemotherapy doublet of topotecan plus paclitaxel in women with recurrent, persis...
  Tewari KS, Sill MW, Monk BJ, Long HJ III, Penson RT, Huang HQ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael H, 44th Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Los Angeles, CA, 1/9/2013
• A limited access phase II trial of pemetrexed in combination with cisplatin in the treatment of advanced, persistent, or recurrent carcioma of the cervix
  Miller DS, Blessing JA, Ramondetta LM, Pham HT, Tewari KS, Landrum LM, Brown J, Mannel RS, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/4/2013
• GOG 240: Incorporation of bevacizumab improves survival in advanced cervical cancer
  Tewari KS, Sill MW, Long HJ III, Penson RT, Huang HQ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael H, Monk BJ, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/4/2013
• Patient reported outcomes in a randomized trial of bevacizumab in the treatment of advanced cervical cancer: A Gynecologic Oncology Group study
  Penson RT, Huang HQ, Tewari KS, Monk BJ, Long HJ III, Ramondetta LM, Landrum LM, Oaknin A, Reid TJA, Leitao MM, Sill MW, Stockman S, Wenzel LB, Annual Meeting, European Cancer Congress, European Society of Medical Oncology, ESMO, Amsterdam, Netherlands, 1/1/2013
• A Gynecologic Oncology Group phase III randomized trial of weekly cisplatin and radiation versus cisplatin and tirapazamine and radiation in stage IB2, IIA, IIB, and I...
  DiSilvestro P, Ali S, Peter C, Spirtos N, Lucci J, Lee Y, Cohn D, Tewari KS, Muller C, Steinhoff M, 43rd Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Austin, TX, 1/24/2012
• Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
  Miller D, Filiaci V, Fleming G, Mannel R, Cohn D, Matsumoto T, Tewari KS, DiSilvestro P, Pearl M, Zaino R, 43rd Annual Meeting on Women�s Cancer, Society of Gynecologic Oncology, Austin, TX, 1/24/2012
• Chemotherapy-induced neutropenia in advanced ovarian carcinoma: An ancillary data study of the Gynecologic Oncology Group
  Gatcliffe TA, Java JJ, Tewari KS, Bookman MA, Monk BJ, 14th Biennial Meeting of the International Gynecologic Cancer Society (IGCS),, Vancouver, BC, Canada, 1/13/2012
• Pathologic findings at risk-reducing salpingo-oophorectomy among women at increased ovarian cancer risk: Results from GOG-199
  Mai PL, Sherman ME, Piedmonte M, Ioffe OB, Ronnett BM, Van Le L, Mutch DG, Cohn DE, Thigpen JT, Tewari KS, Disilvestro P, Kauff ND, Lu KH, Greene MH, J Clin Oncol; Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2012
• Join now to see all

Lectures

• GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase 3 trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in line recurr... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Landmark Careers and Landmark Clinical Trials: Defining the Message for the Next Generation of Gynecologic Oncologists 
  1/22/2014
• Refining therapeutic strategies in advanced cervical cancer: Focus on angiogenesis 
  Manchester Grand Hyatt Hotel, San Diego, CA - 1/7/2014
• History of medicine 
  Irvine, CA - 1/30/2013
• Targeted therapy and immunotherapy in advanced cervical cancer 
  1/20/2013
• GOG 240: Incorporation of bevacizumab improves survival in advanced cervical cancer 
  1/19/2013
• History of cytoreductive surgery 
  Surf and Sand Hotel, Laguna Beach, CA - 1/18/2013
• Development of bevacizumab in the management of recurrent, persistent, and metastatic cervical carcinoma 
  1/17/2013
• The disease spokes: Cervical cancer � Journey from prevention to early detection to the treatment paradigms 
  University of California, Irvine, Irvine, CA - 1/16/2013
• Robotic surgery in gynecologic oncology 
  Apollo Gleneagles Hospital, Kolkata, India, 2013; Apollo Gleneagles Hospital, Delhi, India, 2013 - 1/8/2013
• Transitioning from laparoscopic surgery to robotic surgery in gynecology 
  Apollo Gleneagles Hospital, Kolkata, India - 1/5/2013
• The once and future history of gynecologic oncology: Ovarian cancer � Evolution of the surgical paradigm and landmark clinical trials 
  University of California, Irvine Medical Center, Orange, CA - 1/24/2012
• The once and future history of gynecologic oncology: Ovarian cancer � Angiogenesis, the microenvironment, and immunotherapy 
  University of California, Irvine Medical Center, Orange, CA - 1/24/2012
• Philip John DiSaia � The Gradual Interview: Decade Seven: 1997-2007 
  1/18/2012
• Cancer of the vulva 
  Long Beach, CA - 1/25/2011
• Philip John DiSaia � The Gradual Interview: Decade Six: 1987-1997 
  1/20/2011
• Why philanthropy is critical to the ovarian cancer research mission 
  Costa Mesa, CA - 1/19/2011
• Gynecologic oncology in the 21st Century 
  Multiple locations, 2010, 2011 - 1/14/2011
• Gynecologic cancers 
  UC Irvine Main Campus, Irvine, CA - 1/8/2011
• Landmark clinical trials in gynecologic oncology 
  Orlando, FL - 1/6/2011
• Applications of robotic surgery in gynecologic oncology 
  University of California, Irvine Medical Center, Orange, CA - 1/5/2011
• Management of women with metastatic and recurrent cervical cancer 
  Chicago, IL - 1/4/2011
• Cytoreductive surgery: Instrumentation 
  Surf and Sand Hotel, Laguna Beach, CA - 1/4/2011
• Extra-pelvic colon and small bowel surgery 
  Surf and Sand Hotel, Laguna Beach, CA - 1/4/2011
• Update on prevention, screening, and treatment of cervical cancer 
  Newport Beach, CA - 1/31/2010
• Join now to see all

Other

• Newly diagnosed with ovarian cancer? Start here. In: Special Report � Ovarian Cancer 
  Tewari KS, Women Magazine
  1/1/2014
• The highlights: Advances in screening and management of ovarian cancer � news from Annual Meetings of the Society of Gynecologic Oncology and the American Society of C... 
  Tewari KS, Women Magazine
  1/1/2013
• Supreme Court Ruling a Major Victory for Women�s Health 
  Tewari KS, The Female Patient
  1/1/2012
• Update on Ovarian Cancer Screening and Diagnostic Tests 
  Tewari KS, Women & Cancer Magazine
  1/1/2012
• Timely findings from the ovarian tumor tissue analysis consortium 
  Tewari KS, ASCO Post
  1/1/2012
• Ovarian Cancer Special Edition. The Queen of Hearts Foundation 
  Tewari KS, Women & Cancer Magazine
  1/1/2011
• Update on cervical cancer screening 
  Chase DM, Tewari KS, The Female Patient
  1/1/2010
• Highlights from the 39th Annual Meeting of the Society of Gynecologic Oncologists 
  Tewari KS, Women & Cancer website
  1/1/2008
• Genetic testing for women at high risk of ovarian cancer 
  Tewari KS, Women & Cancer Magazine
  1/1/2008
• Ask the doctor: What is endometrial cancer? 
  Tewari KS, Women & Cancer Magazine
  1/1/2007
• Hope shines brightly for ovarian cancer survivors 
  Tewari KS, Women & Cancer Magazine
  1/1/2007
• Radiation oncology: A guide for Ob/Gyns 
  Tewari KS and DiSaia PJ, OBG Management
  1/1/2001
• Creator, Producer, Editor & Staff Contributor for VITAL SIGNS 
  Tewari KS, UC Irvine College of Medicine
  1/1/1993
• Myths & Facts about Cervical Cancer. What you need to know 
  Tewari KS and Monk BJ, Patient Resource Booklet
• Join now to see all